about
Effects of aberrant Pax6 gene dosage on mouse corneal pathophysiology and corneal epithelial homeostasisNormal X-inactivation mosaicism in corneas of heterozygous FlnaDilp2/+ female mice--a model of human filamin A (FLNA) diseasesEfficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.Increased corneal epithelial turnover contributes to abnormal homeostasis in the Pax6(+/-) mouse model of aniridiaBMP4 signaling directs primitive endoderm-derived XEN cells to an extraembryonic visceral endoderm identity.Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells.Abnormal corneal epithelial maintenance in mice heterozygous for the micropinna microphthalmia mutation MpExpression of podocalyxin separates the hematopoietic and vascular potentials of mouse embryonic stem cell-derived mesoderm.Stem cells and corneal epithelial maintenance: insights from the mouse and other animal modelsModeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.Directed Differentiation of Human Pluripotent Stem Cells to MicrogliaRare corneal clones in mice suggest an age-related decrease of stem cell activity and support the limbal epithelial stem cell hypothesis.Molecular-based diagnosis of multiple sclerosis and its progressive stage.Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells.The sixth annual translational stem cell research conference of the New York Stem Cell Foundation.Oligodendrocyte differentiation of induced pluripotent stem cells derived from subjects with schizophrenias implicate abnormalities in developmentInduction of myelinating oligodendrocytes in human cortical spheroids.Generating induced pluripotent stem cells for multiple sclerosis therapyGFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease
P50
Q34119060-FD0BBF7C-FCE1-4032-B306-1BD704C6F9E3Q34173783-C9BF81ED-79C6-415B-BCD2-EF99A5DEC606Q34250392-F98BE4F6-B4F8-4DDA-8A91-8B103F6357D6Q34963442-C121B523-BBAD-4B92-BC09-AF8D66E18674Q35635745-3E29A2A8-8FDB-4264-B2E4-A6DD12698B2BQ36680149-845908C2-686E-4BC9-B3EB-B1E46B578476Q37153299-8B75CF17-767C-4F1B-891B-17F67EE6D8EFQ37537785-335EEA3F-6812-422E-ACC0-0E919AC2C101Q38037457-A610F6D9-B2C0-4BA9-899A-FAB32DE0939EQ38862033-68514855-B603-4F42-B5FD-5FA3BD48A55DQ41766435-9903C8DB-B7F5-4896-8076-0DA5B60BDACBQ42497649-FB7FC9E4-4129-43FA-9209-E6C7ECF9512DQ47615874-6EA8EB1B-6D87-485D-BC1E-080F5724EBADQ48163616-4BA247E2-C0C5-4B5D-BFB9-65D226CA2C7AQ50954845-FA5BE3F4-1E65-48F6-A890-C54BD9D9126BQ57800211-9F926B23-4FE5-4349-95C0-D60A037EBC04Q65002724-D3850350-C3B7-4A88-A1EB-A756CC23E18DQ86075437-0245FE12-0937-46E7-B289-FFBC4048D4AAQ90740455-0B0FB4ED-B8D8-418D-B883-EA7B3335076D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Panagiotis Douvaras
@ast
Panagiotis Douvaras
@en
Panagiotis Douvaras
@es
Panagiotis Douvaras
@nl
Panagiotis Douvaras
@sl
type
label
Panagiotis Douvaras
@ast
Panagiotis Douvaras
@en
Panagiotis Douvaras
@es
Panagiotis Douvaras
@nl
Panagiotis Douvaras
@sl
prefLabel
Panagiotis Douvaras
@ast
Panagiotis Douvaras
@en
Panagiotis Douvaras
@es
Panagiotis Douvaras
@nl
Panagiotis Douvaras
@sl
P106
P1153
41361049500
P31
P496
0000-0002-4430-997X